Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) market growth at a potential rate of 6.25% in the forecast period till 2028. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an uncommon neurological immune system issue where myelin, a fundamental part of the nervous system is being attacked by the immune system of the body. To attain maximum return on investment (ROI),...